Menu

• Ask a Health Expert about BILE DUCT OBSTRUCTION
• Post Your Side Effect related to BILE DUCT OBSTRUCTION
• BILE DUCT OBSTRUCTION and FDA Warnings
• BILE DUCT OBSTRUCTION in Patients Wiki
• Report BILE DUCT OBSTRUCTION in Drug Side Effect Survey

BILE DUCT OBSTRUCTION side effect

What is BILE DUCT OBSTRUCTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Thalidomide Side Effects Report #5657522-5
Health Professional from UNITED STATES reported THALIDOMIDE problem on Mar 07, 2008. Male patient, weighting 174.2 lb, was diagnosed with prostate cancer and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, international normalised ratio increased, jaundice, . THALIDOMIDE dosage: 100MG ONCE A DAY PO. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5676908-6
ZYPREXA problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . ZYPREXA dosage: 2.5 MG, EACH MORNING. During the same period patient was treated with KLONOPIN. Patient recovered.

Tacrolimus Side Effects Report #5638767-7
Physician from AUSTRALIA reported TACROLIMUS problem on Feb 08, 2008. Female patient, child 9 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, chest pain, cytomegalovirus oesophagitis, haemolytic anaemia, lymphopenia, pyrexia, rash maculo-papular, renal failure, small intestinal obstruction, . TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, AZATHIOPRINEECTION, GANCICLOVIR, PREDNISONE, COTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Cerezyme Side Effects Report #5584895-4
CEREZYME problem was reported by a Physician from UNITED STATES on Dec 24, 2007. Male patient, 41 years of age, weighting 190.0 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . CEREZYME dosage: unknown. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5595622-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 16, 2008. Male patient, 73 years of age, weighting 205.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, sepsis, . BEVACIZUMAB dosage: 930MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.

Tiotropium Side Effects Report #5599030-6
TIOTROPIUM problem was reported by a Consumer or non-health professional from on Jan 16, 2008. Female patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gastrointestinal pain, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Crestor Side Effects Report #5607469-5
Health Professional from CANADA reported CRESTOR problem on Jan 22, 2008. Female patient, 57 years of age, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, hepatic enzyme increased, . CRESTOR dosage: unknown. During the same period patient was treated with RANITIDINE, BISOPROLOL, PHENYTOIN, RISPERIDONE, TYLENOL W. Patient was hospitalized. Patient recovered.

Soriatane Side Effects Report #5614667-3
SORIATANE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Male patient, 62 years of age, weighting 260.0 lb, was diagnosed with psoriasis, blood cholesterol increased and was treated with SORIATANE. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholelithiasis, headache, rash macular, skin disorder, skin inflammation, . SORIATANE dosage: 25 MG; QD; PO. During the same period patient was treated with LIPITOR, LIDEX, PREVACID, VITAMIN CAP. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5535721-0
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Dec 04, 2007. Female patient, weighting 128.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . CARBOPLATIN dosage: 644 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.


Rebif Side Effects Report #5543597-0
REBIF problem was reported by a Physician from UNITED STATES on Nov 28, 2007. Female patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, metastases to liver, oedema peripheral, pancreatic carcinoma metastatic, . REBIF dosage: unknown. Patient was hospitalized. Patient died on 10/25/2007.

Revlimid Side Effects Report #5553460-7
Physician from UNITED STATES reported REVLIMID problem on Dec 03, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, pneumonia, transient ischaemic attack, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5562787-4
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient, weighting 94.80 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, gastrointestinal haemorrhage, neutropenia, white blood cell count increased, . BEVACIZUMAB dosage: 450MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.

Prograf Side Effects Report #5577649-6
Physician from UNITED STATES reported PROGRAF problem on Dec 18, 2007. Male patient, 40 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis chronic, enterococcal infection, escherichia sepsis, impaired gastric emptying, post procedural complication, septic shock, . PROGRAF dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISOLONE ACETATE, LAMIVUDINE, OMEPRAZOLE, INSULIN. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5580503-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Male patient, weighting 112.7 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, condition aggravated, scan abdomen abnormal, . FLUOROURACIL dosage: 9296 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.


Revlimid Side Effects Report #5583590-5
Physician from UNITED STATES reported REVLIMID problem on Dec 26, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, hepatic failure, jaundice cholestatic, . REVLIMID dosage: 15 MG, DAILY, ORAL. During the same period patient was treated with DECADRON, COUMADIN, ALLOPURINOL, POTASSIUM. Patient was hospitalized. Patient died on 10/29/2007.

Forteo Side Effects Report #5505373-4
FORTEO problem was reported by a Consumer or non-health professional from SPAIN on Oct 23, 2007. Female patient, 77 years of age, was diagnosed with osteoporosis, hypertension, pain and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . FORTEO dosage: unknown. During the same period patient was treated with MICARDIS, GELOCATIL. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5507150-7
Consumer or non-health professional from UNITED STATES reported REBIF problem on Oct 23, 2007. Female patient, 48 years of age, weighting 300.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, pancreatitis, pharyngeal disorder, pharyngeal injury, . REBIF dosage: unknown. During the same period patient was treated with COUMADIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Tiotropium Side Effects Report #5512076-9
TIOTROPIUM problem was reported by a Consumer or non-health professional from on Nov 05, 2007. Female patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gastrointestinal pain, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5515210-X
Physician from UNITED STATES reported REVLIMID problem on Oct 29, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gallbladder disorder, pneumonia, transient ischaemic attack, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.


Betaseron Side Effects Report #5520101-4
BETASERON problem was reported by a Consumer or non-health professional from CANADA on Nov 03, 2007. Female patient, 44 years of age, weighting 154.3 lb, was diagnosed with relapsing-remitting multiple sclerosis, hypothyroidism and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholecystectomy, jaundice, musculoskeletal stiffness, stent occlusion, thyroid neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, URSODIOL, CIPRO, FLAGYL, SYNTHROID. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5524651-6
Consumer or non-health professional from CANADA reported BETASERON problem on Nov 20, 2007. Female patient, 44 years of age, weighting 154.3 lb, was diagnosed with relapsing-remitting multiple sclerosis, hypothyroidism and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholecystectomy, jaundice, musculoskeletal stiffness, stent occlusion, thyroid neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, URSODIOL, CIPRO, FLAGYL, SYNTHROID. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5479452-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, hypoxia, transaminases increased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATENOL, COLACE, HUMULIN N, COMPAZINE, ZOFRAN, PROPAFENONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5481996-6
Health Professional from UNITED STATES reported ERLOTINIB problem on Sept 20, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, bile duct stenosis, blood glucose decreased, cholangitis, confusional state, disease progression, pneumonia aspiration, respiratory distress, . ERLOTINIB dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOLOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5498435-1
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, blood glucose decreased, cholangitis, confusional state, disease progression, malignant hepatobiliary neoplasm, pneumonia aspiration, prothrombin time prolonged, . ERLOTINIB dosage: 100MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5448366-8
Physician from UNITED STATES reported REVLIMID problem on Aug 27, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5463526-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, hypoxia, transaminases increased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATENOL, COLACE, HUMULIN N, COMPAZINE, ZOFRAN, PROPAFENONE. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5470195-X
Health Professional from UNITED STATES reported REBIF problem on Sept 11, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholelithiasis, fatigue, gastrointestinal disorder, injection site erythema, injection site pruritus, injection site swelling, multiple sclerosis relapse, post procedural complication, . REBIF dosage: unknown. During the same period patient was treated with CYMBALTA, AMBIEN CR. Patient was hospitalized. Patient recovered.

Actos Side Effects Report #5470867-7
ACTOS problem was reported by a Consumer or non-health professional from GERMANY on Sept 12, 2007. Female patient, 75 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, bile duct stone, . ACTOS dosage: 45 MG (45 MG,1 IN 1 D). During the same period patient was treated with TOREM, METOPROLOL TARTRATE, LISINOPRIL, METFORMIN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5419082-3
Consumer or non-health professional from UNITED STATES reported CETUXIMAB problem on Aug 17, 2007. Female patient was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, jaundice, malignant neoplasm progression, metastases to peritoneum, pancreatic carcinoma metastatic, . CETUXIMAB dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, AMITRIPTYLINE, MORPHINE, TYLENOL. Patient was hospitalized. Patient recovered.

Pravachol Side Effects Report #5429811-0
PRAVACHOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 20, 2007. Male patient was diagnosed with myocardial infarction and was treated with PRAVACHOL. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, liver disorder, . PRAVACHOL dosage: unknown. During the same period patient was treated with TENORMIN, CARDIPRIM, ZYLOPRIM, FOSAMAX, PLAVIX. Patient recovered.

Lapatinib Side Effects Report #5386553-8
Physician from UNITED STATES reported LAPATINIB problem on July 06, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.

Lapatinib Side Effects Report #5395439-4
LAPATINIB problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.

Lapatinib Side Effects Report #5386553-8
Physician from UNITED STATES reported LAPATINIB problem on July 06, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.

Lapatinib Side Effects Report #5395439-4
LAPATINIB problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.

Tracleer Side Effects Report #5760464-8
Physician from UNITED STATES reported TRACLEER problem on May 19, 2008. Female patient, 77 years of age, weighting 216.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholecystitis, cholelithiasis, post procedural bile leak, procedural complication, . TRACLEER dosage: 125 MG, BID, ORAL, 62.5 MG, BID, ORAL, ORAL. Patient was hospitalized. Patient recovered.

Ceftriaxone Side Effects Report #5777472-3
CEFTRIAXONE problem was reported by a Physician from UNITED STATES on June 06, 2008. Female patient, 73 years of age, was diagnosed with phlebitis and was treated with CEFTRIAXONE. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, pancreatitis, . CEFTRIAXONE dosage: unknown. Patient was hospitalized. Patient recovered.

Digoxin Side Effects Report #5797268-6
Consumer or non-health professional from UNITED STATES reported DIGOXIN problem on June 12, 2008. Male patient, 85 years of age, weighting 124.0 lb, was diagnosed with atrial fibrillation and was treated with DIGOXIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cerebral haemorrhage, head injury, hypotension, loss of consciousness, myocardial infarction, . DIGOXIN dosage: 0.125MG,QD,PO. During the same period patient was treated with SYNTHROID, TEGRETOL, ASPIRIN, LOPRESSOR. Patient was hospitalized. Patient died on 04/25/2008.

Avastin Side Effects Report #5728104-1
AVASTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 21, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . AVASTIN dosage: 668 MG, Q2W. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5743552-1
Consumer or non-health professional from COLOMBIA reported PROGRAF problem on May 07, 2008. Male patient, 51 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, liver transplant rejection, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CHOLESTYRAMINE, LORATADINE, LEVOFLOCACIN, CIPROFLOXACIN. Patient recovered.

Rebif Side Effects Report #5744820-X
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2008. Female patient, 26 years of age, weighting 157.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, chest pain, cholelithiasis, jaundice cholestatic, . REBIF dosage: unknown. During the same period patient was treated with BIRTH CONTROL S, COMPAZINE. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5695418-3
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 20, 2008. Female patient, 48 years of age, weighting 303.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, diarrhoea, pancreatitis, vomiting, . REBIF dosage: unknown. During the same period patient was treated with ZANTAC. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5695757-6
ZYPREXA problem was reported by a Physician from UNITED STATES on Mar 25, 2008. Male patient was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholelithiasis, . ZYPREXA dosage: 2.5 MG, EACH MORNING. During the same period patient was treated with KLONOPIN. Patient recovered.

Prograf Side Effects Report #5701253-X
Health Professional from COLOMBIA reported PROGRAF problem on Mar 26, 2008. Female patient, 56 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . PROGRAF dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FOLIC ACID, MICOPHENOLATE. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5702713-8
LAPATINIB problem was reported by a Physician from UNITED STATES on Apr 10, 2008. Female patient, 51 years of age, weighting 186.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, jaundice, pruritus, . LAPATINIB dosage: 1500MG PER DAY. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Interferon Side Effects Report #5350912-X
Consumer or non-health professional from UNITED STATES reported INTERFERON ALFACON problem on May 25, 2007. Male patient, 64 years of age, was diagnosed with hepatitis c and was treated with INTERFERON ALFACON. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, complications of transplanted liver, gastrointestinal haemorrhage, transplant failure, ulcer haemorrhage, white blood cell count decreased, . INTERFERON ALFACON dosage: unknown. During the same period patient was treated with RIBAVIRIN, PANTOPRAZOLE, PROCRIT, VALSARTAN, OXYCODONE, ATIVAN. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5368516-1
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2007. Male patient, 48 years of age, weighting 183.0 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, blood potassium decreased, chromaturia, jaundice, ocular icterus, pancreatic carcinoma, pancreatic duct obstruction, pancreatitis, vomiting, . AVONEX dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, HYDROCODONE BITARTRATE, RANITIDINE, BACLOFEN, MORPHINE, PANCRECARB, DOXYCYCLINE. Patient died on 05/27/2007.

Lapatinib Side Effects Report #5320194-3
Physician from UNITED STATES reported LAPATINIB problem on May 04, 2007. Female patient, 39 years of age, weighting 130.1 lb, was diagnosed with breast cancer metastatic and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Seftem Side Effects Report #5325847-9
SEFTEM problem was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, 52 years of age, was diagnosed with upper respiratory tract inflammation, stevens-johnson syndrome and was treated with SEFTEM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, cholestasis, cytomegalovirus enteritis, disseminated cytomegaloviral infection, liver disorder, small intestinal perforation, stevens-johnson syndrome, . SEFTEM dosage: unknown. During the same period patient was treated with PREDONINE, PRANOPROFEN, METHYLPREDNISOLONE, URSODIOL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5326721-4
Physician from UNITED STATES reported BEVACIZUMAB problem on May 14, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, hypoxia, transaminases increased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATENOL, COLACE, HUMULIN N, COMPAZINE, ZOFRAN, PROPAFENONE. Patient was hospitalized. Patient recovered.

Zelnorm Side Effects Report #5328273-1
ZELNORM problem was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2007. Male patient, 91 years of age, was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, biliary tract operation, cholecystectomy, cholelithiasis, deep vein thrombosis, . ZELNORM dosage: unknown. Patient was hospitalized. Patient died on 04/01/2007.

Zelnorm Side Effects Report #5334279-9
Consumer or non-health professional from UNITED STATES reported ZELNORM problem on May 21, 2007. Male patient, 91 years of age, was diagnosed with constipation and was treated with ZELNORM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, biliary tract operation, cholecystectomy, cholelithiasis, deep vein thrombosis, . ZELNORM dosage: unknown. Patient was hospitalized. Patient died on 04/01/2007.